Jim Simons T2 Biosystems, Inc. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$0.86 - $1.21 $1.92 Million - $2.71 Million	-2,237,496 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.04 - $1.69 $1.62 Million - $2.64 Million	1,560,000 Added 230.26%	2,237,496 $2.66 Million
Q1 2021 May 13, 2021	BUY	$1.32 - $3.79 $894,294 - $2.57 Million	677,496 New	677,496 $1.1 Million
Q1 2019 May 14, 2019	SELL	$2.56 - $4.48 $427,008 - $747,264	-166,800 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$2.98 - $6.86 $497,064 - $1.14 Million	166,800 New	166,800 $502,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.53M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.